Introduction
Migraine is a common episodic neurological disorder with an annual prevalence of 5.6% in males and 17.1% in females in the United States of America (Lipton et al., 2007) . Clinical diagnosis is established using International Classification of Headache Disorders-II (ICHD-II) criterion, which recognises 2 forms of migraine: migraine with aura (MA) and migraine without aura (MO) (ICHD-II, 2004 ). These two types of migraine are differentiated by the presence or absence of aura, a reversible focal neurological symptom preceding or accompanying the headache phase of an attack. Individuals may experience MA, MO or a combination of both forms of migraine with varying frequency throughout life. The headache is thought to be caused by activation of the trigeminovascular system and the aura by spreading depression, a slow propagating wave of neuronal and glial depolarization that spreads across the cortex (Goadsby et al., 2009; Hadjikhani et al., 2001) .
Migraine is a complex, multifactorial disorder for which the aetiology is not fully understood. The disorder displays strong familial aggregation, with first degree relatives of MO and MA probands having an increased relative risk of developing the disorder compared to the general population (Colongo et al., 2003; Stewart et al., 2006; Stewart et al., 1997) . Recent population based twin studies report heritability estimates to range from 0.34 to 0.57 (Mulder et al., 2003; Svensson et al., 2003) .
The complex nature of migraine is evident from international pedigree studies that have so far reported linkage regions on chromosomes 1q31 (Lea et al., 2002) , 4q21 (Björnsson et al., 2003) , 4q24 (Wessman et al., 2002) , 4q28 (Anttila et al., 2006) , 5q21 (Nyholt et al., 2005) , 6p12.2-p21.1 (Carlsson et al., 2002 ), 10q22-23 (Anttila et al., 2008 ), 10q25.3 (Lafreniere et al., 2010 , 11q24 (Cader et al., 2003) , 14q21.2-q22.3 (Soragna et al., 2003) , 15q11-q13 (Russo et al., 2005) , 17p13 (Anttila et al., 2006) , 18q12 (Anttila et al., 2006 ), 19p13 (Jones et al., 2001 Nyholt et al., 1998a) and Xq24-28 (Nyholt, 2000; Nyholt et al., 1998b) .
Pedigree studies conducted to date have made significant contributions to understanding the complex aetiology of migraine. This study aimed to validate existing and/or discover new migraine susceptibility loci by conducting heritability and genome-wide linkage analyses in a large affected pedigree from the geographically isolated population of Norfolk Island.
Materials and methods

Sample ascertainment
Data collection procedures have been previously described in a demographic investigation of CVD risk phenotypes (Bellis et al., 2005) , with the study protocol approved by Griffith University Human Research Ethics Committee prior to commencement. All subjects provided a signed, informed consent prior to participation. In brief, subjects were ascertained based on permanent resident status (not selected on phenotypes of interest), to ensure sampling of individuals from the same genealogical background. Phenotypic data and biological specimens were obtained from 600 subjects (261 males, 339 females) with a mean age of 50.8 years (standard deviation of 16.4 years). All biological samples were from venous blood. Genealogical data was obtained via questionnaire, and municipal and historical records.
Phenotyping
Migraine was diagnosed in accordance with current ICHD-II using interviews with a migraine questionnaire and followed up by qualified migraine diagnostician (ICHD-II, 2004) . Under the hypothesis of a common major gene, all individuals diagnosed with subtypes MA and/or MO were grouped together and phenotyped as being affected with migraine.
Pedigree reconstruction and validation
Norfolk Island census data indicate a large portion of the permanent residents are of Pitcairn descent (Matthews, 2001) . These individuals are related through a 6379-member, 10-generation genealogy founded by Isle of Man Bounty Mutineers and their Tahitian consorts in 1790. At the commencement of the Norfolk Island Health Study in 2000, it was hypothesised that the ascertained subjects (n = 600) resided within the last five generations of the genealogy. All 600 participants were genotyped for 400 genome wide microsatellite markers to validate relationship status of all individuals in the sample population using identity-by-descent matrices (Bellis et al., 2008) . PREST analysis produced an inferred pedigree structure of 6537, which was inflated from 6379 because of the coding of missing parents.
The size and complexity of the original genealogical structure (N = 6537) and large volume of missing data prohibited direct use in variance component linkage analysis (Bellis et al., 2008) . Hence, the pedigree was split (N = 1078) using a peeling algorithm in the pedigree database management system PEDSYS (Southwest Foundation for Biomedical Research, San Antonio, Texas, USA) to facilitate analysis (Dyke, 1996) . This 1078 member pedigree has been previously employed in genome-wide screens of cardiovascular risk traits (Bellis et al., 2008) . A total of 377 (171 males, 206 females) of the 600 participants are related through this multigenerational pedigree and included in the linkage analysis.
Genotyping
The genome screen included 400 highly polymorphic autosomal microsatellites markers genotyped across all 600 participants. Markers had an average spacing of 10 cM throughout the human genome. All PCRs were performed under standard conditions using fluorescently labelled primer pairs. Markers were organised into multiplex panels and electrophoresed on a 3730 DNA Analyzer (Applied Biosystems). Data was analysed using Applied Biosystems Genescan version 3.1 and Genotyper version 2.1 software. Sex-averaged chromosomal maps were obtained from the Marshfield Centre for Medical Genetics (http://research.marshfieldclinic.org/genetics). Pedigree structure validation, elimination of typing errors and estimation of multipoint identity-by-descent allele sharing matrices have been described (Bellis et al., 2008) .
Statistical analyses
Heritability (h 2 ) was estimated as the ratio of the trait variance that is explained by additive polygenic effects to total phenotypic variance of the trait (Göring et al., 2001 ) using the Sequential Oligonucleotide Linkage Analysis Routines (SOLAR) v4.0.6 software package (Texas Biomedical Research Institute, San Antonio, Texas, USA). The polygenic model applied assumes an infinite number of genetic factors with a small additive effect contributing to the trait variance. Estimates were screened for the covariate effects of age, age-squared, sex and their interactions to allow for differential symptom prevalence in males and females and adjust for the variable age of onset.
Covariates with P-values less than or equal to 0.05 were retained in the final model. Heritability was measured on a scale ranging from 0 to 1. A value of 0 indicates the phenotype is completely controlled by non-genetic (environmental) factors. As the score approaches 1 the genetic component increases. Linkage was tested throughout the genome using multipoint variance component analysis. This method localises QTLs for dichotomous traits by assuming the trait has a latent liability threshold with an underlying multivariate normal distribution (Duggirala et al., 1997) . All heritability estimations and linkage analyses utilise maximum likelihood, variance component methods implemented in the SOLAR v4.0.6 software package (Almasy and Blangero, 1998) . Like parametric LOD scores, under the null hypothesis of no linkage, the variance component LOD score is distributed as an equal mixture of a chi-square random variable at point mass of 0 and a degree of freedom of 1 . As a result, point-wise Pvalues can be estimated for each LOD score value using the method described by Nyholt (2000) . A SOLAR LOD score of 3.0, 2.1, 1.2 and 0.59 equates to pointwise P values of 1 × 10 − 4 , 1×10
and 0.05, respectively. Previous studies of CVD risk determined the current trimmed pedigree structure had good power to detect the heritability of phenotypes whose variation is partially attributable to additive genetics and to detect loci for such phenotypes (Bellis et al., 2007) . 
Validation cohort
Important findings were further assessed in 223 unrelated Norfolk Island Health Study participants (90 males; 133 females) included in the initial genome wide scan but genetically unrelated to the core pedigree. This unrelated sub-population included 58 migraineurs (41 MA; 17 MO). Allelic association was tested at polymorphic loci implicated in the pedigree genome wide linkage scan using the programme CLUMP (Sham and Curtis, 1995) . CLUMP performs chisquared tests for allelic association employing an empirical Monte Carlo test of significance that does not require correction for multiple alleles at a highly polymorphic locus. A total of four 'chi-squared' test statistics are generated for each marker analysed. Three of these tests combine rare alleles present in a marker data set by collapsing adjacent columns before performing the chi-squared test.
Results
This study aimed to define the genetic basis of migraine within an extended pedigree from the isolated population of Norfolk Island whose origins date to the infamous 'mutiny on the Bounty'. We identified a total of 154 (25.7%) migraine cases in the full cohort and a total of 96 (25.5%) migraine cases in 377-member core pedigree (Table 1) . These pedigree individuals were integrated into subsequent heritability and linkage analyses. A heritability of 0.53 was estimated for migraine (P = 0.016). The high prevalence and heritability of migraine in this pedigree imply its suitability for mapping susceptibility loci via linkage analysis.
The maximum LOD score obtained in our study was 1.60 (pointwise P = 0.003) on chromosome 13q33.1 nearest marker D13S158 (102 cM). The 1-LOD-unit support interval around the linkage peak on chromosome 13q was approximately 26 cM long, extending between markers D13S265 and D13S1265. Potential evidence of linkage (LOD >1.2) was also detected for migraine on chromosome 9q22.32 (100 cM) nearest marker D9S287 with a LOD score of 1.26 (pointwise P = 0.008). Additional linkage peaks were identified on chromosome 2, 4, 10 and 12 exceeding the threshold for nominal significance (LOD ≥0.59; point wise P ≤ 0.05). Results are detailed in Table 2 .
Replication cohort
Genome-wide genotype data was available for all 600 Norfolk Island participants to establish pedigree membership. Of these individuals, 223 individuals were genetically unrelated to the core pedigree and therefore suitable for assessing the validity of the linkage results.
From the genome scan of the pedigree, two microsatellites D9S287 and D13S158 provided some evidence for linkage with migraine. These two markers were tested in the unrelated sub-population using the programme CLUMP. Using this method, both D9S287 and D13S173 provided evidence for association with migraine (Table 3) . D9S287 was significant with an empirical P-value of 0.04 for the CLUMP T3 test. In the region surrounding D13S158, microsatellite D13S173 was significant for the CLUMP T1, T2 and T3 tests with empirical P-values of, 0.05, 0.01 and 0.05, respectively.
Discussion
The Norfolk population isolate is a unique island community. It is of particular interest for gene mapping as the current population structure includes a very large multigenerational pedigree derived from 17 founding individuals, as well as cultural and geographical isolation leading to reduced genetic and environmental diversity. The current investigation assessed migraine using autosomal genome wide STR data in an effort to identify susceptibility loci. A high prevalence of migraine was observed -twice that compared to most outbred populations (25% v 12%). Variance components methods showed a migraine heritability of 0.53 using the 377-member core Norfolk pedigree. This is consistent with population-based twin studies, which estimate heritability for migraine to vary from 0.34 to 0.57 (Honkasalo et al., 1995; Larsson et al., 1995; Mulder et al., 2003; Svensson et al., 2003; Ziegler et al., 1998) . Although the present study did not analyse migraine subtypes, heritability estimates of 0.65 are reported for MA and 0.61 for MO for population-based twin studies.
After detecting a significant genetic component, linkage to the migraine phenotype was tested across the autosomes. A region of potential interest was detected on chromosome 9q22.32, residing near a familial occipitotemporal lobe epilepsy and combined MA locus on chromosome 9q21-q22 (MIM 611631) (Deprez et al., 2007) . Near the linkage peak detected in the Norfolk pedigree resides the gabbaaminobutyric acid-B receptor type 2 (GABBR2; MIM 607340) gene on chromosome 9q22.1. This gene is a receptor for the major inhibitory neurotransmitter in the brain, gabba-amino-butyric acid (GABA). GABA type B receptors are a family of g-protein coupled receptors widely expressed in the peripheral and central nervous system that inhibit or depress synaptic transmission via second messenger coupling (Kornau, 2006) . Common variants in the GABBR2 have been positively associated with mesial temporal lobe epilepsy (Wanga et al., 2008) . The 9q22.32 linkage peak supports the findings of the Deprez et al. (2007) study and may be of further interest considering the potential gene candidate, GABBR2 located in close proximity to the 9q22.32 locus.
In addition to the chromosome 9q22.32 locus, a linkage peak of potential interest also occurred on chromosome 13q (LOD = 1.60; point-wise P = 0.003). The 1-LOD-support interval spanned 13q33.1 to 13q33.3. The peak marker D13S158, is within 10 cM of a locus linked previously to migraine symptom phenotype, pulsation (LOD = 3.31; P = 0.00005) in a large Dutch cohort (Ligthart et al., 2008) . Interestingly, other neurological disorders display linkage and association to chromosome 13q32-34. A bipolar locus is reported at 13q32-q33 (Badner and Gershon, 2002) and the 13q-related schizophrenia susceptibility locus (SCZD7; MIM 603176) at 13q34 (Chumakov et al., 2002) . Both bipolar disorder and schizophrenia display association with variants in the D-amino acid oxidase activator gene located at 13q34 (DAOA; MIM 607408) (Chumakov et al., 2002; Hattori et al., 2003) . DAOA encodes a protein that is expressed in the human brain and is involved in degrading D-serine, a potent activator of N-methyl-D-aspartate-type glutamate receptor (NMDAR2D; MIM 602717) (Chumakov et al., 2002) . Glutamate is a major excitatory neurotransmitter in the mammalian central nervous system. Disruption of normal glutamate homeostasis is hypothesised to contribute to the pathogenesis of a range of neurological disorders, including migraine (Vikelis and Mitsikostas, 2007) . Given current knowledge of the chromosome 13q32-34 locus in bipolar disorder and schizophrenia, as well as the close proximity of the potential gene candidate DAOA, further assessment of this region in terms of migraine is warranted. Upon further assessment, evidence of validation was detected for the chromosome 9 peak marker and chromosome 13 markers in a subpopulation of 223 genetically unrelated individuals. Positive allelic association in non-pedigree members strengthens the linkage signals and suggests further studies are warranted using this unique Island population. Aside from the overlap of chromosome 9 and 13 regions with some neurological phenotypes and the presence of a gene candidate under each peak, no replication (LOD ≥0.59; point wise P ≤ 0.05) of previously known migraine loci was observed.
Conclusion
This study performed heritability and linkage analysis of migraine in an extended pedigree from the Norfolk Island isolate. We identified a high prevalence and heritability of migraine in this pedigree. Peak linkage signals occurred on chromosomes 9q22.22 and 13q33.1. Focussing on these regions, nominal evidence of validation was detected in an unrelated sub-population also from Norfolk Island. These linkage peaks overlap with regions reported for familial occipitotemporal lobe epilepsy and combined MA, migraine trait symptom 'pulsation' and bipolar disorder. On-going recruitment of pedigree members, analysis of additional markers from dense SNP arrays and analysis in outbred populations may strengthen and refine these results.
